Cancer treatment often involves surgery, chemotherapy, and radiation therapy. While these remain the standard medical approaches, there is increasing interest in complementary therapies that can help improve patients’ quality of life and support recovery. One such integrative option is Mistletoe Therapy, developed and researched extensively by ABNOBA GmbH, a German pharmaceutical manufacturer known for its dedication to science-based natural medicine.
What is Mistletoe Therapy?
Mistletoe (Viscum album) is a medicinal plant traditionally used in Europe for its therapeutic properties. Extracts from mistletoe are prepared as injectable formulations and administered under medical supervision. In oncology, mistletoe therapy is used alongside conventional cancer treatments, not as a replacement, but as a supportive care option.
How Does It Work?
Research suggests that mistletoe extracts may:
-
Stimulate the immune system
-
Improve tolerance to chemotherapy and radiation
-
Enhance overall well-being and reduce fatigue
-
Support emotional balance and better quality of life
Some studies also indicate potential benefits in tumor growth regulation, though mistletoe therapy is primarily recognized as a complementary approach to reduce side effects and strengthen resilience.
ABNOBA’s Commitment to Cancer Care
ABNOBA GmbH, based in Pforzheim, Germany, is a research-driven company specializing in mistletoe preparations. Through decades of clinical research and patient care, ABNOBA has contributed significantly to the integration of mistletoe therapy in oncology worldwide.
In India, ABNOBA India brings this expertise closer to patients and healthcare professionals seeking holistic cancer care solutions.
Conclusion
Mistletoe cancer therapy offers hope as a natural companion to conventional treatments, focusing on improving quality of life and supporting the body’s healing capacity. Patients interested in mistletoe therapy should always consult their oncologist or an integrative medicine specialist to explore if it may be suitable for their individual case.
